Sort
46,585 grants matching “heart failure”
Atherosclerosis Risk in Communities Study (ARIC)
$1,178,318Josef Coresh · Johns Hopkins University · N01 · FY2009 · HL
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe
$1,177,039Katherine S Panageas · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
NEUROCIRCULATORY FUNCTION IN CHRONIC HEART FAILURE
$1,176,856University Of Nebraska Medical Center · P01 · FY2003 · HL
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease
$1,176,595Jianyi Zhang · University Of Alabama At Birmingham · U01 · FY2019 · HL
Program Project in Biomedical Outcomes of Aging
$1,176,418Massachusetts General Hospital · P01 · FY2004 · AG
Biosynthesis, Processing And Secretion Of Neuropeptides And Pituitary Hormones
$1,175,868Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Center for African American Urban Health
$1,175,326Wayne State University · P50 · FY2005 · ES
The Look AHEAD Continuation: Action for Health in Diabetes
$1,175,089Karen C Johnson · University Of Tennessee Health Sci Ctr · U01 · FY2009 · DK
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
$1,174,176Steven A Webber · Vanderbilt University · U01 · FY2013 · AI
Apical Access System with Universal Connector for Beating Heart LVAD Implantation
$1,173,971Jorge Hernan Jimenez · Apk Advanced Medical Technologies, Inc. · R44 · FY2015 · HL
Heart Failure Adherence and Retention Trial (HART)
$1,173,937Rush University Medical Center · R01 · FY2004 · HL
2-HOBA for Treatment of Pulmonary Hypertension
$1,173,060John A Rathmacher · Mti Biotech, Inc. · R42 · FY2023 · HL
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease
$1,172,627Jianyi Zhang · University Of Alabama At Birmingham · U01 · FY2020 · HL
CIF: Medium: Iterative Quantum LDPC Decoders
$1,171,862Bane Vasic · University Of Arizona · · FY2019 · CSE
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
$1,171,075Mark Thomas Gladwin · University Of Maryland Baltimore · UH3 · FY2025 · HL
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
$1,170,955Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · UH3 · FY2021 · HL
The ISCHEMIA-CKD Trial-CCC-Lead Application
$1,170,175Sripal Bangalore · New York University School Of Medicine · U01 · FY2018 · HL
ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - COHORT VISIT 7PERIOD OF PERFORMANCE - NOVEMBER 1, 2017 - DECEMBER 15, 2019
$1,169,984Aaron Folsom · University Of Minnesota · N01 · FY2018 · HL
CORAL: Clinical Coordinating Center
$1,169,702Christopher J Cooper · University Of Toledo Health Sci Campus · U01 · FY2008 · HL
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
$1,169,083Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · UH3 · FY2020 · HL
Health Outcomes of Weight loss: Look AHEAD -Action for Health in Diabetes
$1,168,807George Bray · Lsu Pennington Biomedical Research Ctr · U01 · FY2007 · DK
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease
$1,168,782Jianyi Zhang · University Of Alabama At Birmingham · U01 · FY2021 · HL
Look AHEAD: Action for Health in Diabetes
$1,168,583Frederick L Brancati · Johns Hopkins University · U01 · FY2012 · DK
SCH: Interpretable survival analysis of complex longitudinal data
$1,168,412Michele Santacatterina · New York University Medical Center · · FY2023 · CSE
Health Outcomes of Weight loss: Look AHEAD -Action for Health in Diabetes
$1,168,062Robert W Jeffery · University Of Minnesota · U01 · FY2007 · DK